Global Study Finds CAR-T Cell Therapy Associated with Elevated Risk of Secondary Primary Malignancies
In recent years, chimeric antigen receptor T-cell (CAR-T) therapy has emerged as a transformative approach to treating refractory hematologic malignancies. ...